| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/13/1999 | US5922735 4-aryl-3-hydroxyquinolin-2-one derivatives as ion channel modulators |
| 07/13/1999 | US5922734 Novel compounds for treating psoriasis and methods for their synthesis |
| 07/13/1999 | US5922733 Administering to treat central nervous system disorders such as anxiety, depression, epilepsy, obsessive compulsive disorders, anorexia, bulimia and alzheimer's disease |
| 07/13/1999 | US5922731 Anxiolytic agents, antiepileptic agents, anticonvulsants; treatment for sleeplessness, muscle spasms, benzodiazepinedrug overdose |
| 07/13/1999 | US5922728 Phenylsubstituted 4-azasteroid fluoroderivatives |
| 07/13/1999 | US5922727 Antiviral substituted pyrimidinedione homocarbocyclic nucleoside derivatives and methods for the preparation thereof and compositions containing the same as active ingredients |
| 07/13/1999 | US5922725 Benzimidazole compounds and their use as modulators of the GABAA receptor complex |
| 07/13/1999 | US5922724 Benzimidazole compounds and their use as modulators of the GABA a receptor complex |
| 07/13/1999 | US5922722 Alpha 1a adrenergic receptor antagonists |
| 07/13/1999 | US5922720 Pharmaceutical for use in treatment of diseases based on helicobacter bacteria |
| 07/13/1999 | US5922719 Coumarin dopamine D4 receptor antagonists |
| 07/13/1999 | US5922718 Triazolones as apolipoprotein-B synthesis inhibitors |
| 07/13/1999 | US5922717 Piperazine derivatives, medicaments comprising these compounds, their use and processes for their preparation |
| 07/13/1999 | US5922716 Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (ampa) receptor antagonists, non-competitive n-methyl-d-aspartate (nmda) receptor antagonists |
| 07/13/1999 | US5922714 Mixture containing 4-amino-g-methyleneqlutamic acid |
| 07/13/1999 | US5922713 Inhibition of nitric oxide synthase |
| 07/13/1999 | US5922712 Administering triazolopyridazine derivative for treating the diseases involving eosinophilia, such as alleric rhinitis, and atopic dermatitis |
| 07/13/1999 | US5922711 Antiallergens, antiinflammatory agents, autoimmune diseases, shock or analgesics |
| 07/13/1999 | US5922709 Synergistic |
| 07/13/1999 | US5922708 Heteroaryl-oxazolidinones |
| 07/13/1999 | US5922707 Oxazolidinone antibacterial agent with tricyclic substituents |
| 07/13/1999 | US5922705 Rapid narcotic detoxification |
| 07/13/1999 | US5922703 Useful for treating congestive heart failure |
| 07/13/1999 | US5922702 Administering ecdysone compound amtoprotozoa agent to digestive tract of ruminant animal |
| 07/13/1999 | US5922701 Method for enhancing or accelerating re-epithelialization or re-endothelialization of a tissue |
| 07/13/1999 | US5922700 Kit for drug delivery of steroids |
| 07/13/1999 | US5922699 Affecting certain consequent behavior and physiology, e.g., the reduction of anxiety |
| 07/13/1999 | US5922697 Compounds, compositions and methods for inhibiting the binding of proteins containing an SH2 domain to cognate phosphorylated proteins |
| 07/13/1999 | US5922696 Ethylenic and allenic phosphonate derivatives of purines |
| 07/13/1999 | US5922691 Crystalline maltotetraosyl glucoside, and its production and use |
| 07/13/1999 | US5922690 Having at least 2 sulfate groups per disaccharide obtained by chemical sulfation of native dermatan sulfate. |
| 07/13/1999 | US5922689 Cisplatin analogs for cancer treatment |
| 07/13/1999 | US5922687 Placing the nucleic acid in an extracellular environment of the cell, defining an enclosure comprising the cell and the extracellular environmenat, establishing an incubation pressure within the enclosure; useful for gene therapy |
| 07/13/1999 | US5922684 Polyhydro derivatives of tylosine and process for their preparation |
| 07/13/1999 | US5922674 Inhibiting endothelial cell proliferation in a subject treated by with platinum coordination complex chemotherapeutic agent by simultaneous administration of erythropoietin |
| 07/13/1999 | US5922582 Indole alkaloid type compound 0089-D |
| 07/13/1999 | US5922580 Contacting a reducing partial starch hydrolysate with a novel enzyme which forms a non-reducing saccharide in the absence of trehalose; glucoamylase and glycosidase yield trehalose when allowed to act on the non-reducing saccharide |
| 07/13/1999 | US5922546 Human disintegrin metalloprotease KUZ gene |
| 07/13/1999 | US5922510 A blends comprising acrylic linear copolymer, an ethylenically-unsaturated compound and a photoinitiator for coating printed circuit boards, the ethylenically-unsaturated compound forming a polymer under photoinitiator and radiation |
| 07/13/1999 | US5922358 Antithrombotic and non-hemorrhagic heparin-based compositions, process for their preparation and therapeutic applications |
| 07/13/1999 | US5922354 Methods and system for processing dispersible fine powders |
| 07/13/1999 | US5922350 Dehydration in presence of sugars present at a protectiveconcentration on both inside and outside surfaces; liposomeshave ion concentration gradient capable of generatingtransmember potential to load charged material |
| 07/13/1999 | US5922349 Dispensing non-discrete doses of estrogen and progestogen concurrently onto delivery surface and transferring dispensed doses to site of administration, repeating the procedure on predetermined schedule, periodically varying dosage |
| 07/13/1999 | US5922347 Low water content, separated spatially form basic component;rapid absorption; good tolerance in mouth; high bioavailabiltiy; storage stability |
| 07/13/1999 | US5922346 A mixtures of reduced glutathione, selenium or a selenium compound for reducing free radical damage induced by tobacco products and environmental pollutants |
| 07/13/1999 | US5922345 Nutrition |
| 07/13/1999 | US5922341 Administering an antidepressant, antiserotonin agent or adrenergic blocking agent |
| 07/13/1999 | US5922340 Administering with glucocorticoid; sustained release |
| 07/13/1999 | US5922335 Skin disorders and oxidation resitance |
| 07/13/1999 | US5922332 Topical delivery of arginine to overcome pain |
| 07/13/1999 | US5922314 Skin preparation composition |
| 07/13/1999 | US5922313 Lotion consists of a mixture of polyvinylpyrrolidone and hydroxyethyl cellulose, an antibacterial agent chlorhexidine digluconate or 2,4,4'-trichloro-2'-hydroxydiphenylether, blend of glyceryl stearate and polyethylene glycol emulsifer |
| 07/13/1999 | US5922306 Inhalants dispersion comprising tetrafluoroethane/1,1,1,2-/ propellant, drug particles precoated with surfactant, the drug formulation consists of betamethasone, ergotamine tartrate or sodium cromoglycate for respiratory system disorders |
| 07/13/1999 | US5922253 Production scale method of forming microparticles |
| 07/13/1999 | CA2258445A1 Compositions for the reduction of scarring |
| 07/13/1999 | CA2176037C Antithrombotic amidinophenylalanine and amidinopyridylalanine derivatives |
| 07/13/1999 | CA2162249C Cholesterol lowering drink mix compositions |
| 07/13/1999 | CA2159985C Methods of using hesperetin for sebum control and treatment of acne |
| 07/13/1999 | CA2148074C Cosmetic or pharmaceutical composition for topical use |
| 07/13/1999 | CA2146212C Cosmetic or pharmaceutical composition containing an alkyl carbamate as a hydrating agent |
| 07/13/1999 | CA2129144C Reversal of multi-drug resistance by triphenyl-azacycloalkane derivatives |
| 07/13/1999 | CA2118489C 5-o-desosaminylerythronolide a derivatives |
| 07/13/1999 | CA2044154C Method of assaying d-vanillylmandelic acid, and reagent and kit therefor |
| 07/13/1999 | CA2033044C 6-substituted purine carbocyclic nucleosides |
| 07/13/1999 | CA2005980C Benzimidazole derivative with gastric acid inhibitory effect and process for its preparation |
| 07/13/1999 | CA1340653C Method for improving reproductive functions in mammals |
| 07/13/1999 | CA1340645C Acid stable dideoxynucleosides active against the cytopathic effects of human immunodeficiency virus |
| 07/13/1999 | CA1340640C Regulation of enzymes which utilize tetrahydrobiopterin or tetrahydrofolate cofactors with 6,6-disubstituted-tetrahydropteridines |
| 07/12/1999 | CA2258166A1 Process for the preparation of 3-amino-pyrrolidine derivatives |
| 07/08/1999 | WO1999034018A1 Methods of using chemical libraries to search for new kinase inhibitors |
| 07/08/1999 | WO1999033981A2 Human signal peptide-containing proteins |
| 07/08/1999 | WO1999033974A1 Serine proteinase inhibitors |
| 07/08/1999 | WO1999033970A1 Medicinal compositions for treating or preventing influenza and novel capped oligoribonucleotides |
| 07/08/1999 | WO1999033958A2 Desaturase |
| 07/08/1999 | WO1999033859A2 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
| 07/08/1999 | WO1999033858A2 Estrone sulfamate inhibitors of estrone sulfatase, and associated pharmaceutical compositions and methods of use |
| 07/08/1999 | WO1999033857A1 Bone-resorptive cytokine inhibitor containing dienogest as the active ingredient |
| 07/08/1999 | WO1999033856A1 Neovascularization inhibitor containing dienogest as the active ingredient |
| 07/08/1999 | WO1999033855A1 11β-HALOGEN-7α-SUBSTITUTED ESTRATRIENES, METHOD FOR PRODUCING PHARMACEUTICAL PREPARATIONS CONTAINING SAID 11β-HALOGEN-7α-SUBSTITUTED ESTRATRIENES AND USE OF THE SAME FOR PRODUCING MEDICAMENTS |
| 07/08/1999 | WO1999033853A2 Carbohydrates, useful in solid delivery systems |
| 07/08/1999 | WO1999033851A1 N-het-substituted glycerophosphoethanolamines |
| 07/08/1999 | WO1999033850A1 NOVEL β-LACTAMASE AND DD-PEPTIDASE INHIBITORS |
| 07/08/1999 | WO1999033849A1 Prodrugs of naaladase inhibitors |
| 07/08/1999 | WO1999033847A1 Phosphinic alkanoic acid derivatives |
| 07/08/1999 | WO1999033846A2 Water soluble prodrugs of secondary and tertiary amine containing drugs and methods of making thereof |
| 07/08/1999 | WO1999033841A2 Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha-1-blocking action |
| 07/08/1999 | WO1999033840A2 Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha1-blocking action |
| 07/08/1999 | WO1999033838A1 2-β-SUBSTITUTED-6-ALKYLIDENE PENICILLANIC ACID DERIVATIVES AS β-LACTAMASE INHIBITORS |
| 07/08/1999 | WO1999033836A1 3'-epimeric k-252a derivatives |
| 07/08/1999 | WO1999033834A1 Novel farnesyl transferase inhibitors, preparation, pharmaceutical compositions containing them and use for preparing medicines |
| 07/08/1999 | WO1999033833A1 Metallocorrinoids as biologically compatible carriers of pharmacological agents |
| 07/08/1999 | WO1999033832A1 Cytotoxic alkaloid derivatives including asmarine a and b isolated from a sponge |
| 07/08/1999 | WO1999033831A1 Nitrogen-containing heterocyclic compounds, their production and use |
| 07/08/1999 | WO1999033829A1 Novel camptothecin tetracyclic analogues, preparation, methods, applications as medicines and pharmaceutical compositions containing them |
| 07/08/1999 | WO1999033828A1 Benzo[c]quinolizine derivatives and their use as 5 alpha-reductases inhibitors |
| 07/08/1999 | WO1999033827A1 Novel imidazole derivatives |
| 07/08/1999 | WO1999033825A1 N-phenylamide and n-pyridylamide derivatives, method of preparing them and pharmaceutical compositons containing them |
| 07/08/1999 | WO1999033824A1 Heterocyclic topoisomerase poisons |
| 07/08/1999 | WO1999033822A1 Indole derivatives useful a.o. for the treatment of osteoporosis |
| 07/08/1999 | WO1999033821A1 Benzopyran and benzothiopyran derivatives having retinoid antagonist-like activity |